Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients.

Authors:
Shimasaki Y; Miyoshi H; Kawamoto K; Yoshida N; Mishina T and 16 more

Journal:
Cancer Med

Publication Year: 2024

DOI:
10.1002/cam4.6793

PMCID:
PMC10905534

PMID:
38234210

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cancer Med

Abbreviation: Cancer Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER reg…
Tavakkoli A; Beauchamp A; Prasad T and 7 more (2024) - Transparency Score: 4/6
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S; Revon-Riviere G; Grover SA and 17 more (2024) - Transparency Score: 3/6
A comprehensive narrative review of challenges and facilitators in the implementation of various HP…
Aggarwal S; Agarwal P; Gupta N. (2024) - Transparency Score: 3/6
A computed tomography urography-based machine learning model for predicting preoperative pathologic…
Zheng Y; Shi H; Fu S and 6 more (2024) - Transparency Score: 3/6
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequenci…
Zazo S; Pérez-Buira S; Carvajal N and 12 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025